APTORUM GROUP LTD-CLASS A (APM)
KYG6096M1226 - Common Stock
Taking everything into account, APM scores 2 out of 10 in our fundamental rating. APM was compared to 588 industry peers in the Biotechnology industry. APM has a bad profitability rating. Also its financial health evaluation is rather negative. APM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year APM has reported negative net income.
APM had a negative operating cash flow in the past year.
APM had negative earnings in 4 of the past 5 years.
In the past 5 years APM always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -92.96%, APM is not doing good in the industry: 75.09% of the companies in the same industry are doing better.
With a decent Return On Equity value of -61.33%, APM is doing good in the industry, outperforming 60.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.96% | ||
| ROE | -61.33% | ||
| ROIC | N/A |
ROA(3y)-49.01%
ROA(5y)-51.59%
ROE(3y)-51.13%
ROE(5y)-62.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
APM's Gross Margin of 7.10% is fine compared to the rest of the industry. APM outperforms 74.40% of its industry peers.
The Profit Margin and Operating Margin are not available for APM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
APM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, APM has less shares outstanding
Compared to 5 years ago, APM has more shares outstanding
APM has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -12.37, we must say that APM is in the distress zone and has some risk of bankruptcy.
APM has a Altman-Z score of -12.37. This is amonst the worse of the industry: APM underperforms 81.23% of its industry peers.
APM has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.00, APM perfoms like the industry average, outperforming 47.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.37 |
ROIC/WACCN/A
WACC7.9%
2.3 Liquidity
APM has a Current Ratio of 1.32. This is a normal value and indicates that APM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, APM is doing worse than 85.84% of the companies in the same industry.
A Quick Ratio of 1.32 indicates that APM should not have too much problems paying its short term obligations.
APM has a worse Quick ratio (1.32) than 83.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
The earnings per share for APM have decreased strongly by -19.91% in the last year.
The Revenue for APM has decreased by -15.99% in the past year. This is quite bad
The Revenue has been growing by 34.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-19.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-168.94%
Revenue 1Y (TTM)-15.99%
Revenue growth 3Y34.02%
Revenue growth 5YN/A
Revenue growth Q2Q-18.61%
3.2 Future
Based on estimates for the next years, APM will show a very strong growth in Earnings Per Share. The EPS will grow by 139.86% on average per year.
Based on estimates for the next years, APM will show a very strong growth in Revenue. The Revenue will grow by 114.52% on average per year.
EPS Next Y-6%
EPS Next 2Y36.38%
EPS Next 3Y139.86%
EPS Next 5YN/A
Revenue Next Year107.16%
Revenue Next 2Y1287.8%
Revenue Next 3Y246.29%
Revenue Next 5Y114.52%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
APM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year APM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
APM's earnings are expected to grow with 139.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.38%
EPS Next 3Y139.86%
5. Dividend
5.1 Amount
APM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APTORUM GROUP LTD-CLASS A
NASDAQ:APM (4/26/2024, 7:00:00 PM)
After market: 5.5 +0.22 (+4.17%)5.28
-0.2 (-3.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap27.35M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.96% | ||
| ROE | -61.33% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.1% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-19.91%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.99%
Revenue growth 3Y34.02%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y